ARCHIVES

Radiation To Stem Cell Niche Improved PFS In Glioblastoma

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial

January 27, 2012

New Grants In Ovarian Cancer Ok’d In Concepts By DCBDC Advisors

March 27, 1992

Ontak Approved For Lymphoma

October 31, 2008

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

April 6, 2012

Tumor Classification, Monoclonal Antibody Announcements Made

January 7, 1983

NKTR-102 Shows 29 Percent Response in Phase II Study

September 30, 2011